Rankings
▼
Calendar
XOMAP Q1 2025 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena
XOMAP
XOMA Corporation
$311M
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$16M
+967.9% YoY
Gross Profit
$15M
91.9% margin
Operating Income
$6M
37.3% margin
Net Income
$2M
14.9% margin
EPS (Diluted)
$0.06
QoQ Revenue Growth
+82.6%
Cash Flow
Operating Cash Flow
$2M
Free Cash Flow
$2M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$213M
Total Liabilities
$128M
Stockholders' Equity
$85M
Cash & Equivalents
$90M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$16M
$1M
+967.9%
Gross Profit
$15M
$1M
+882.5%
Operating Income
$6M
-$7M
+184.7%
Net Income
$2M
-$9M
+127.5%
← Q4 2024
All Quarters
Q2 2025 →